By staying alert to skin symptoms and knowing what to look for you can take the first steps toward addressing a potential ...

A review highlighting the need to improve vitiligo care through understanding the role of the JAK-STAT pathway, early diagnosis ...

Research indicates elevated cardiovascular risk in vitiligo patients, underscoring the necessity for enhanced monitoring and ...

The Centers for Medicare & Medicaid Services (CMS) selected Belle.ai as one of six inaugural participants in the first quarterly CMS Artificial Intelligence Demo Day, held Nov. 7 at CMS's headquarters ...

People with vitiligo often need to use many medicines every day to help regain pigment in their skin and reduce other side effects. Some people may use light therapy, pills, or surgery to help ...

"Notably, the study found that the thresholds for meaningful change are lower than those typically established in clinical ...

Investigators conducted a systemic review to summarize evidence regarding the use systemic Janus kinase inhibitors in patients with refractory nonsegmental vitiligo.

A new study found that vitiligo is associated with a significant risk of cardiovascular diseases compared to healthy ...

VYN201 Phase 2b vitiligo trial exceeds enrollment target; Expected to be fully enrolled in December 2024 with top-line results on track for ...

TD Cowen analyst Tyler Van Buren maintained a Buy rating on Arcutis Biotherapeutics (ARQT – Research Report) today and set a price target ...

Thomas Bieber, University of Bonn, Germany, wasted no time in welcoming his colleagues from around the world to the ...